Check-Cap Ltd. (CHEK) Social Stream



Check-Cap Ltd. (CHEK): $1.14

0.01 (-0.87%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

CHECK-CAP LTD (CHEK) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CHECK-CAP LTD.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-14 2 $3 $3 $3 $2 50%
2022-09-02 2 $3 $1 $2 $2 0%
2022-12-02 2 $15 $15 $15 $2 650%
2023-05-15 2 $7 $7 $7 $2 250%
NA 2 $NA $NA $NA $2 NA%

The Trend in the Analyst Price Target


CHEK's average price target has moved up $5.25 over the prior 28 months.

Over the past 40 days, CHEK's average upside potential has been 424.41%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-05 2 7 7 7 1.32 430.3%
2023-05-15 2 7 7 7 1.35 418.52%

CHEK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


CHEK's average broker recommendation rating improved by 0 over the prior 18 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CHECK-CAP LTD's number of analysts covering the stock is higher than 16.98% of all US stocks.
  • In the context of all US stocks, CHECK-CAP LTD's variance in analysts' estimates is lower than 11.81% of them.
  • In terms of how CHECK-CAP LTD fares relative to Healthcare stocks, note that its average analyst price target is higher than 108.64% of that group.
  • To contextualize these metrics, consider that out of Medical Equipment stocks, CHECK-CAP LTD's upside potential (average analyst target price relative to current price) is greater than 332.33% of them.

Stocks similar to CHECK-CAP LTD in the Medical Equipment industry regarding analyst recommendations and price targets are MOVE, PYPD, and ICU.

Make investment decisions regarding CHEK using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!